1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account

Human Renin for clinical researchers available from Lee Biosolutions, Inc

Lee Biosolutions, Inc announces increased inventory levels for high purity native human renin and high purity recombinant human renin for Clinical researchers world wide due to increase demand.

FOR IMMEDIATE RELEASE

PRLog (Press Release) - Nov 14, 2007 -
ST. LOUIS , MO.  Lee Biosolutions, Inc (http://www.leebio.com) announces increased inventory levels for high purity native human renin and high purity recombinant human renin for Clinical researchers world wide.

Renin is a key enzyme produced and released by the kidneys which initiates a cascade of reactions leading to the formation of Angiotensin II, which helps control sodium-potassium balance, fluid volume and blood pressure in the body. Renin plays a critical role in the diagnosis and treatment of a variety of conditions including hypertension, cirrhosis, renal tumors, Addisons disease, and Conns syndrome.

Human Renin (http://www.leebio.com/products/details.html?uid=249')  acts as a proteolytic enzyme of the kidney by releasing angiotensin which has a vasoconstrictive action which results in a higher blood pressure. Early detection of Human renin level increases related to a blood pressure increase have shown in research to provide vital prognostic and diagnostic guidelines for evaluating possible surgical treatment especially in renovascular involvement

According to  President ,Burton Lee recombinant  Human renin ( http://www.leebio.com/products/details.html?uid=312 ) has been most popular among X-Ray crystallographers  studying the  Renin-Angiotensin System.  Crystallographic Recombinant human renin is produced from crystallographic grade recombinant human pro-renin which is expressed in HEK cells, converted to renin, and the  active enzyme was purified using peptide affinity chromatography.  

Novartis Pharmaceuticals announced the first daily-dose Renin inhibitor to treat hypertension and improve organ protection in March 2005. Since then, Renin-based research has taken off and become the focus of numerous clinical studies.

Lee Biosolutions is a leader in the biomaterials industry, providing quality biomaterial products to clinical labs and researchers around the world, developing tomorrows cures. Leebio has provided human proteins used in a number of high profile biomarker studies. For more information or to place an order, contact

Lee Biosolutions, Inc
2924 Mary Ave
St. Louis, MO 63144
Tel:t 314-968-1091,
www.LeeBio.com.

# # #

Lee Biosolutions, Inc specializes in the development and purification of high quality BioMarkers for the Immunodiagnostic, clinical diagnostic and pharmaceutical industry worldwide. We supply reliable high quality human and animal enzymes and proteins, cardiac markers, tumor markers, acute phase proteins, coagulation proteins and immunoassay biomarkers

--- end ---

Click to Share

Contact Email:
Source:Lee Biosolutions, Inc
Website:http://www.leebio.com
Phone:314-968-1091
Address:2924 Mary Ave
Zip:63144
City/Town:St. Louis
State/Province:Missouri
Country:United States
Industry:Health, Medical, Business
Tags:angiotensinogen, renin, , renin-angiotensin system, , , , , ,
Shortcut:http://prlog.org/10037928
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
3.5K1.4K1.3K
Click to Share